Found 9 matching trials
A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia
PHASE2This study will identify the optimum concentrations of AGN-199201 and AGN-1...
Location
Sall Research Medical Center
Using AGN-190584 in Subjects Utilizing Single -Use Daily, Contact Lenses
PHASE4AGN-190584 has gone through many clinical trials showing its safety and eff...
Location
Multiple Locations
Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia
PHASE2A study to evaluate the safety and efficacy of AGN-199201 alone, AGN-190584...
Location
Multiple Locations
Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia
PHASE2Presbyopia is a condition in which the eye exhibits a diminished ability to...
Location
Trinity Research Group /ID# 243541
A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily
PHASE3Currently available treatments for presbyopia (old eye) include nonsurgical...
Location
Empire Eye and Laser /ID# 231433
A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age
PHASE3The purpose of this study is to evaluate night-driving performance in real-...
Location
School of Optometry and Vision Science, Queensland University of Technology /ID# 226378
A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia
PHASE3This clinical study will evaluate pilocarpine hydrogen chloride (HCl) ophth...
Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia
PHASE3A study to evaluate the efficacy, safety, and pharmacokinetics of pilocarpi...
Location
Arizona Eye Center
A Safety, Efficacy and Pharmacokinetic Study of AGN-199201 and AGN-190584 in Patients With Presbyopia
PHASE2This is a safety, efficacy and pharmacokinetics study of the fixed combinat...
Location
Retina Institute of California Medical Group